Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Fusion | 20 | 2026 | 156 | 4.200 |
Why?
|
| Lumbar Vertebrae | 16 | 2026 | 174 | 4.180 |
Why?
|
| Cervical Vertebrae | 10 | 2024 | 119 | 2.060 |
Why?
|
| Spondylolisthesis | 7 | 2026 | 49 | 1.810 |
Why?
|
| Diskectomy | 6 | 2023 | 37 | 1.790 |
Why?
|
| Spondylosis | 6 | 2024 | 26 | 1.560 |
Why?
|
| Intervertebral Disc Displacement | 4 | 2019 | 17 | 1.530 |
Why?
|
| Neurosurgical Procedures | 7 | 2016 | 104 | 1.160 |
Why?
|
| Cost-Benefit Analysis | 10 | 2026 | 315 | 0.950 |
Why?
|
| Spinal Diseases | 6 | 2020 | 49 | 0.930 |
Why?
|
| Foraminotomy | 2 | 2023 | 2 | 0.910 |
Why?
|
| Spinal Stenosis | 4 | 2025 | 32 | 0.910 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2024 | 160 | 0.900 |
Why?
|
| Radiculopathy | 2 | 2023 | 21 | 0.900 |
Why?
|
| Spine | 3 | 2015 | 52 | 0.850 |
Why?
|
| Disability Evaluation | 4 | 2019 | 216 | 0.730 |
Why?
|
| Decompression, Surgical | 5 | 2024 | 70 | 0.690 |
Why?
|
| Postoperative Complications | 7 | 2021 | 1314 | 0.670 |
Why?
|
| Brain Injuries | 2 | 2013 | 141 | 0.670 |
Why?
|
| Anxiety | 1 | 2024 | 425 | 0.660 |
Why?
|
| Treatment Outcome | 19 | 2025 | 5775 | 0.660 |
Why?
|
| Health Care Costs | 2 | 2013 | 223 | 0.650 |
Why?
|
| Low Back Pain | 1 | 2019 | 112 | 0.570 |
Why?
|
| Analgesics, Opioid | 2 | 2020 | 525 | 0.540 |
Why?
|
| Quality of Life | 8 | 2019 | 1257 | 0.530 |
Why?
|
| Costs and Cost Analysis | 3 | 2012 | 105 | 0.530 |
Why?
|
| Neurosurgery | 2 | 2022 | 31 | 0.530 |
Why?
|
| Middle Aged | 28 | 2025 | 18169 | 0.520 |
Why?
|
| Depression | 1 | 2024 | 897 | 0.510 |
Why?
|
| Orthopedic Procedures | 3 | 2015 | 54 | 0.510 |
Why?
|
| Humans | 47 | 2026 | 64901 | 0.490 |
Why?
|
| Opioid-Related Disorders | 2 | 2020 | 524 | 0.470 |
Why?
|
| Aged | 21 | 2025 | 14882 | 0.460 |
Why?
|
| Male | 29 | 2025 | 30898 | 0.450 |
Why?
|
| Spinal Cord Diseases | 4 | 2024 | 44 | 0.430 |
Why?
|
| Prospective Studies | 11 | 2024 | 3303 | 0.400 |
Why?
|
| Thoracic Vertebrae | 3 | 2015 | 35 | 0.400 |
Why?
|
| Spinal Canal | 1 | 2013 | 5 | 0.400 |
Why?
|
| Female | 26 | 2025 | 33861 | 0.390 |
Why?
|
| Spinal Cord Compression | 1 | 2013 | 30 | 0.390 |
Why?
|
| Spinal Cord Injuries | 1 | 2013 | 54 | 0.380 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 34 | 0.370 |
Why?
|
| Orthopedics | 1 | 2012 | 33 | 0.360 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2011 | 18 | 0.350 |
Why?
|
| Dura Mater | 1 | 2011 | 32 | 0.350 |
Why?
|
| Laminectomy | 3 | 2025 | 25 | 0.350 |
Why?
|
| Oligodendroglioma | 2 | 2009 | 7 | 0.340 |
Why?
|
| Lung Diseases | 1 | 2012 | 182 | 0.320 |
Why?
|
| Retrospective Studies | 10 | 2024 | 6823 | 0.320 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2011 | 109 | 0.320 |
Why?
|
| Neuroma, Acoustic | 1 | 2010 | 8 | 0.320 |
Why?
|
| Loss of Heterozygosity | 2 | 2009 | 25 | 0.280 |
Why?
|
| Adult | 15 | 2024 | 17278 | 0.280 |
Why?
|
| Reoperation | 4 | 2019 | 300 | 0.280 |
Why?
|
| Follow-Up Studies | 10 | 2021 | 2483 | 0.280 |
Why?
|
| Pneumocephalus | 1 | 2008 | 5 | 0.280 |
Why?
|
| Rhinitis | 1 | 2008 | 15 | 0.270 |
Why?
|
| Decision Support Techniques | 1 | 2010 | 193 | 0.270 |
Why?
|
| Sinusitis | 1 | 2008 | 21 | 0.270 |
Why?
|
| Monitoring, Intraoperative | 2 | 2012 | 47 | 0.270 |
Why?
|
| Brain Neoplasms | 2 | 2009 | 318 | 0.270 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2009 | 186 | 0.260 |
Why?
|
| Endoscopy | 1 | 2008 | 94 | 0.260 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 27 | 0.250 |
Why?
|
| Hypertension | 1 | 2012 | 610 | 0.250 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 5582 | 0.250 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2006 | 27 | 0.250 |
Why?
|
| Calcinosis | 1 | 2006 | 84 | 0.240 |
Why?
|
| Laminoplasty | 1 | 2024 | 4 | 0.210 |
Why?
|
| Return to Work | 1 | 2024 | 26 | 0.210 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2016 | 63 | 0.210 |
Why?
|
| Comorbidity | 4 | 2020 | 1112 | 0.200 |
Why?
|
| Neck | 1 | 2023 | 45 | 0.190 |
Why?
|
| Pedicle Screws | 1 | 2022 | 3 | 0.190 |
Why?
|
| Outpatients | 1 | 2022 | 142 | 0.180 |
Why?
|
| Multicenter Studies as Topic | 2 | 2019 | 156 | 0.180 |
Why?
|
| Registries | 2 | 2015 | 902 | 0.160 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1557 | 0.160 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 67 | 0.150 |
Why?
|
| Clinical Trials, Phase IV as Topic | 1 | 2019 | 2 | 0.150 |
Why?
|
| Blood Volume | 2 | 2011 | 40 | 0.150 |
Why?
|
| Societies, Medical | 1 | 2022 | 399 | 0.150 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2019 | 26 | 0.150 |
Why?
|
| Radiography | 3 | 2021 | 556 | 0.150 |
Why?
|
| Health Status | 2 | 2019 | 448 | 0.150 |
Why?
|
| Inappropriate Prescribing | 1 | 2019 | 68 | 0.150 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 1103 | 0.140 |
Why?
|
| Radiology | 1 | 2022 | 260 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2019 | 200 | 0.140 |
Why?
|
| Propensity Score | 1 | 2019 | 189 | 0.140 |
Why?
|
| United States | 6 | 2022 | 8062 | 0.140 |
Why?
|
| Arachnoid Cysts | 1 | 2016 | 6 | 0.130 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2016 | 5 | 0.130 |
Why?
|
| Pain | 1 | 2019 | 398 | 0.120 |
Why?
|
| Bone Transplantation | 2 | 2016 | 31 | 0.120 |
Why?
|
| Jehovah's Witnesses | 1 | 2016 | 19 | 0.120 |
Why?
|
| Craniotomy | 2 | 2016 | 20 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 49 | 0.120 |
Why?
|
| Brain Diseases | 1 | 2016 | 76 | 0.120 |
Why?
|
| Blood Transfusion | 1 | 2016 | 164 | 0.110 |
Why?
|
| Incidence | 3 | 2015 | 1412 | 0.110 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 89 | 0.110 |
Why?
|
| Models, Economic | 1 | 2014 | 42 | 0.110 |
Why?
|
| Medicare | 2 | 2022 | 620 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2021 | 2238 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 735 | 0.100 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 434 | 0.100 |
Why?
|
| Hospital Charges | 1 | 2012 | 22 | 0.100 |
Why?
|
| Arthroplasty | 2 | 2022 | 7 | 0.090 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2012 | 64 | 0.090 |
Why?
|
| Decompressive Craniectomy | 1 | 2012 | 5 | 0.090 |
Why?
|
| Bone Screws | 1 | 2012 | 35 | 0.090 |
Why?
|
| Glasgow Outcome Scale | 1 | 2012 | 17 | 0.090 |
Why?
|
| Intracranial Pressure | 1 | 2012 | 19 | 0.090 |
Why?
|
| Constriction, Pathologic | 2 | 2022 | 131 | 0.090 |
Why?
|
| Glasgow Coma Scale | 1 | 2012 | 48 | 0.090 |
Why?
|
| Diagnosis-Related Groups | 1 | 2012 | 86 | 0.090 |
Why?
|
| Erythrocyte Count | 1 | 2011 | 15 | 0.090 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2012 | 43 | 0.090 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 97 | 0.090 |
Why?
|
| Cost of Illness | 1 | 2013 | 171 | 0.090 |
Why?
|
| Cerebrospinal Fluid | 1 | 2011 | 29 | 0.090 |
Why?
|
| Tumor Burden | 2 | 2011 | 75 | 0.090 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2011 | 5 | 0.090 |
Why?
|
| Bone Plates | 1 | 2011 | 41 | 0.090 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2011 | 2 | 0.090 |
Why?
|
| Thoracic Neoplasms | 1 | 2011 | 14 | 0.090 |
Why?
|
| Spinal Neoplasms | 1 | 2011 | 16 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 195 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 162 | 0.080 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2011 | 56 | 0.080 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 105 | 0.080 |
Why?
|
| Tinnitus | 1 | 2010 | 16 | 0.080 |
Why?
|
| Watchful Waiting | 1 | 2010 | 32 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 928 | 0.080 |
Why?
|
| Microsurgery | 1 | 2010 | 54 | 0.080 |
Why?
|
| Accidents, Traffic | 2 | 2011 | 140 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2011 | 138 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 229 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2010 | 67 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 17 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2009 | 23 | 0.070 |
Why?
|
| Hearing Loss | 1 | 2010 | 53 | 0.070 |
Why?
|
| Patient Selection | 2 | 2025 | 483 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 140 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2009 | 127 | 0.070 |
Why?
|
| Young Adult | 3 | 2015 | 4783 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2011 | 335 | 0.070 |
Why?
|
| Skull Base | 1 | 2008 | 12 | 0.070 |
Why?
|
| Age Factors | 1 | 2012 | 1579 | 0.070 |
Why?
|
| ROC Curve | 2 | 2020 | 292 | 0.070 |
Why?
|
| Vertebral Artery | 1 | 2006 | 29 | 0.060 |
Why?
|
| Demography | 2 | 2016 | 178 | 0.060 |
Why?
|
| Cerebral Angiography | 1 | 2006 | 297 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2008 | 741 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 1 | 2006 | 240 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 2284 | 0.050 |
Why?
|
| Cyclic N-Oxides | 1 | 2022 | 1 | 0.050 |
Why?
|
| Risk Factors | 2 | 2015 | 5404 | 0.050 |
Why?
|
| Neurosurgeons | 1 | 2022 | 7 | 0.050 |
Why?
|
| Back Pain | 1 | 2022 | 49 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2004 | 533 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2022 | 126 | 0.040 |
Why?
|
| New England | 1 | 2022 | 269 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2022 | 178 | 0.040 |
Why?
|
| Triage | 1 | 2022 | 134 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2022 | 231 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2020 | 149 | 0.040 |
Why?
|
| Leadership | 1 | 2022 | 211 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2021 | 207 | 0.040 |
Why?
|
| HIV-1 | 1 | 2004 | 705 | 0.040 |
Why?
|
| Fishes | 1 | 1978 | 22 | 0.040 |
Why?
|
| Trace Elements | 1 | 1978 | 22 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2022 | 435 | 0.040 |
Why?
|
| HIV Infections | 1 | 2004 | 956 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 2757 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 14 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 65 | 0.030 |
Why?
|
| Ohio | 1 | 2016 | 24 | 0.030 |
Why?
|
| Decision Trees | 1 | 2016 | 48 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2016 | 136 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 140 | 0.030 |
Why?
|
| Perioperative Period | 1 | 2015 | 20 | 0.030 |
Why?
|
| Animals | 2 | 2011 | 21341 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2016 | 340 | 0.030 |
Why?
|
| Adolescent | 3 | 2015 | 6283 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2015 | 136 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 56 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1134 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 1654 | 0.020 |
Why?
|
| Lumbosacral Region | 1 | 2012 | 21 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2016 | 1009 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 800 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 456 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2015 | 881 | 0.020 |
Why?
|
| Atlanto-Axial Joint | 1 | 2011 | 3 | 0.020 |
Why?
|
| Breath Tests | 1 | 1991 | 14 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 585 | 0.020 |
Why?
|
| Child Restraint Systems | 1 | 2011 | 6 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2011 | 53 | 0.020 |
Why?
|
| Thoracoscopy | 1 | 2011 | 29 | 0.020 |
Why?
|
| Fracture Fixation | 1 | 2011 | 18 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 2011 | 25 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2011 | 47 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2011 | 67 | 0.020 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2011 | 37 | 0.020 |
Why?
|
| Air Pollution, Indoor | 1 | 1991 | 38 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2011 | 50 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 370 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2011 | 99 | 0.020 |
Why?
|
| Air Pollutants | 1 | 1991 | 98 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 454 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 161 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2609 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 543 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 699 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 522 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2004 | 11 | 0.010 |
Why?
|
| Giant Cells | 1 | 2004 | 16 | 0.010 |
Why?
|
| CD40 Ligand | 1 | 2004 | 158 | 0.010 |
Why?
|
| Plasma Cells | 1 | 2004 | 52 | 0.010 |
Why?
|
| Child | 2 | 2011 | 4601 | 0.010 |
Why?
|
| Virulence | 1 | 2004 | 201 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 2004 | 101 | 0.010 |
Why?
|
| Antibodies | 1 | 2004 | 187 | 0.010 |
Why?
|
| Cell Death | 1 | 2004 | 289 | 0.010 |
Why?
|
| Virus Replication | 1 | 2004 | 323 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 2190 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2004 | 1385 | 0.010 |
Why?
|
| South Carolina | 1 | 1978 | 15 | 0.010 |
Why?
|
| United States Environmental Protection Agency | 1 | 1991 | 7 | 0.010 |
Why?
|
| Los Angeles | 1 | 1991 | 14 | 0.010 |
Why?
|
| Water Pollutants, Chemical | 1 | 1991 | 42 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 1991 | 154 | 0.000 |
Why?
|